General
Preferred name
BACITRACIN
Synonyms
BACITRACIN ZINC ()
bacitracin A ()
Fortracin ()
NSC-755905 ()
Baci-Rx ()
Bacilliquin ()
Parentracin ()
Tropitracin ()
Baciguent ()
Bacitracin(non-injectable) ()
Zutracin ()
Baciim ()
Penitracin ()
Bacitracinum ()
Bacitracin, sterile ()
Baciferm 50 ()
Topitracin ()
E700 ()
Albac 50 ()
Bacitracinum zincum ()
Bacitracins, zinc complex ()
Noptracin ()
Zinc bacitracin ()
Bacitracins zinc complex ()
Bacifarmin ()
Ziba-RX ()
Bacitracin A (technical grade) ()
P&D ID
PD009882
CAS
1405-87-4
22601-59-8
Tags
natural product
drug
available
Drug Status
approved
vet_approved
Drug indication
Skin infection
Antibacterial
Max Phase
Phase 4
First approval
1957
1948
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Bacitracin A is a polypeptide antibacterial with activity against Gram-positive bacteria. It is the major component of bacitracin , a mixture of at least nine closely-related cyclic polypeptides produced by Bacillus licheniformis and Bacillus subtilis. (GtoPdb)
INDICATION For the treatment of infants with pneumonia and empyema caused by staphylococci shown to be susceptible to the drug. Also used in ointment form for topical treatment of a variety of localized skin and eye infections, as well as for the prevention of wound infections. Used against gram positive bacteria. Bacitracin is also used as an inhibitor of proteases and other enzymes. ; However, specific activity of bactracin's inhibition of protein disulfide isomerase has been called into question.
Compound Sets
10
Cayman Chemical Bioactives
ChEMBL Approved Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
External IDs
40
Properties
(calculated by RDKit )
Molecular Weight
1421.75
Hydrogen Bond Acceptors
19
Hydrogen Bond Donors
17
Rotatable Bonds
31
Ring Count
4
Aromatic Ring Count
2
cLogP
-1.68
TPSA
530.87
Fraction CSP3
0.64
Chiral centers
15.0
Largest ring
25.0
QED
0.04
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Indication
first-aid antibiotic
Target
IDE
MOA
bacterial cell wall synthesis inhibitor
Therapeutic Class
Antibiotics
Source data